Navigation Links
Clarity on Cosmetic Injectable Labeling and Use
Date:4/14/2008

NEW YORK, April 14 /PRNewswire-USNewswire/ -- When it comes to cosmetic injectables, the terms "investigational" and "off-label" are often used interchangeably, often confusing consumers. The Physicians Coalition for Injectable Safety offers consumers these guidelines and definitions:

"A label containing specific consumer safety information is required by the Food and Drug Administration after a drug or medical device has been approved," explained Coalition leader Roger Dailey, MD of Portland, OR. "There are very specific labeling requirements including things such as brand name, drug content, the indications for a drug or device, dosing, adverse reactions, warnings and even data obtained from clinical studies."

A label defines the specific use for which a drug has been approved. "Off-label use refers to the legal practice of prescribing a drug for a purpose other than its stated indication; this is up to your doctors' discretion and is commonly done, however it is illegal for a manufacturer to market, advertise or otherwise promote the off-label use of drugs," said Coalition member Mark A. Codner, MD of Atlanta, GA. "For example, most dermal fillers are specifically approved for use in the nasolabial folds, the creases that run from the outer corner of the nose to the outer corner of the mouth. As a result, other forms of tissue enhancement that are commonly addressed with dermal fillers are considered 'off-label' as these specific treatments were not part of the clinical data submitted for approval," he continued.

"The term investigational means that either a drug or device is being studied in a particular application as part of the process necessary to submit for approval to the U.S. FDA, or that an approved drug or device is being studied for new uses," explained Dr. Dailey. "For example, consider that Botox(R) is approved for many clinical applications and Botox(R) Cosmetic is approved for cosmetic use. However, there is no approval similar or specific to the treatment of headaches with Botox(R), therefore this is an investigational use -- one that is being studied by physician-investigators."

A complete listing of FDA-approved cosmetic injectables with common off-label uses, and a listing of investigational cosmetic injectables and uses are available in the "Injectables-at-a-Glance" link at InjectableSafety.org. A full glossary of commonly used terms can also be found on the site.

A "Cosmetic Injectable Planner" is also available to download in PDF format, an ideal and easy-to-use set of guidelines for planning a first time or repeat cosmetic injectable treatment. The Coalition offers consumers these very simple questions to ask before considering any cosmetic injectable procedure:

-- Doctor: Is the injectable recommended by a qualified doctor who regularly treats similar conditions, in an appropriately licensed and equipped medical facility? Has the doctor examined the prospective patient before recommending treatment?

-- Brand: Is the injectable recommended approved by the U.S. FDA for cosmetic indications and is it appropriately labeled and packaged to reflect its authenticity and approval?

-- Safety: Is the setting a proper medically-equipped office, with safety and sterilization procedures? Has the physician evaluated conditions, recommended treatment, offered alternatives and clearly defined the potential outcomes including any complications?

For the latest consumer safety and education and cosmetic injectables and more visit http://www.injectablesafety.org.

About Us

The Physicians Coalition for Injectable Safety is an alliance of specialty physician organizations including the American Society for Aesthetic Plastic Surgery, American Academy of Facial Plastic and Reconstructive Surgery, and the American Society of Ophthalmic Plastic and Reconstructive Surgery. The mission of the Coalition is to provide the public with unbiased and necessary information on injectable cosmetic treatments, appropriate injectors and where to safely access cosmetic medical procedures. Our goal is to promote treatment supervised by properly qualified and trained, board-certified doctors and to promote only the use of U.S. FDA-approved, appropriately administered product. More information can be found at http://www.injectablesafety.org.

About ASAPS

The 2400-member American Society for Aesthetic Plastic Surgery (ASAPS), founded in 1967, is the leading professional organization of plastic surgeons certified by the American Board of Plastic Surgery who specialize in cosmetic plastic surgery. With 2,100 members in the U.S., Canada, and many other countries, ASAPS is at the forefront of innovation in aesthetic plastic surgery around the world.

About AAFPRS

The American Academy of Facial Plastic and Reconstructive Surgery is the world's largest specialty association that represents over 2,700 facial plastic and reconstructive surgeons throughout the world. The AAFPRS is a National Medical Specialty Society of the American Medical Association (AMA), and holds an official seat in both the AMA House of Delegates and the American College of Surgeons board of governors. AAFPRS members are board certified surgeons whose focus is surgery of the face, head, and neck.

About ASOPRS

The American Society of Ophthalmic Plastic and Reconstructive Surgery represent surgeons qualified in plastic surgery of the eyelids and surrounding facial structures. Fellows of the Society are board certified in ophthalmology, have completed fellowships in oculofacialplastic surgery (currently two years), and perform aesthetic, plastic, and reconstructive surgery of the face, orbits, eyelids, and lacrimal system.


'/>"/>
SOURCE Physicians Coalition for Injectable Safety
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Clarity for Consumers on Botox Complication and Death Reports
2. Experts Offer Clarity on Confusion Surrounding Stents
3. A New Kind of New Years Resolution Could Bring Clarity to Americans
4. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
5. Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar
6. Cosmetic Plastic Surgery Procedures for Ethnic Patients up 13 Percent in 2007
7. 2007 procedural survey reveals a 2 year increase in age of patients seeking cosmetic surgery
8. 2007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery
9. Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox
10. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
11. Leading Natural Cosmetics Company Supports Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
(Date:5/26/2016)... ... , ... Despite last week’s media reports hinting at a June rate hike ... March 2017 for an interest rate increase, according to Rajeev Dhawan of the Economic ... Federal Open Market Committee (FOMC) dot charts are of interest to the press for ...
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... skin care products, has been honored with a 2016 When Work Works Award for ... prestigious award, part of the national When Work Works project administered by the Families ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... , May 25, 2016 ... & Expo earlier this month, the numbers and momentum ... continue to climb into the billions, more research and ... released 4th Edition State of Legal Marijuana Markets Report ... cannabis-focused data-analysis firm, much of the increase in sector ...
(Date:5/25/2016)... May 25, 2016 Inivata, ... precision of circulating tumour DNA (ctDNA) analysis to ... appointment of Professor Clive Morris as ... across the clinical development programme, scientific collaborations, and ... deliver significant improvements in clinical outcomes for patients. ...
Breaking Medicine Technology: